Skip to main content
Top
Published in: Diagnostic Pathology 1/2008

Open Access 01-12-2008 | Proceedings

Tissue microarrays: applications in study of p16 and p53 alterations in Ewing's cell lines

Authors: Rosa Noguera, Isidro Machado, Marta Piqueras, Jose Antonio Lopez-Guerrero, Samuel Navarro, Empar Mayordomo, Antonio Pellin, Antonio Llombart-Bosch

Published in: Diagnostic Pathology | Special Issue 1/2008

Login to get access

Abstract

Background

Tissue microarrays (TMAs) are used to study genomics and proteomics in several tumour tissue samples. Cell lines (CC) are of great importance in the study of the genetic changes in tumours, and some reveal several aspects of tumour oncogenesis. There are few published reports on Ewing's tumours with TMAs including original tumours (OT) and corresponding CC.

Methods

We have performed four TMAs, from 3 OT and the corresponding CC of successive in vivo and in vitro tumour passages. Xenotransplant CC in nude mice from OT (XT/OT) was made. Subsequently multiple XT were performed and in vitro XT cell line (CC/XT) was obtained. In vivo re-inoculation of CC/XT (XT/CC) was planned. TMAs with the successive tumour passages that grew in nude mice (XT/OT and XT/CC) were analyzed by morphologic pattern (Hematoxilin/eosin), immunohistochemical staining (CD99, FLI1, p16, p53, ki-67), fluorescent in situ hybridization-FISH-(EWSR1 break apart, p16 and p53 status) and gene fusion types.

Results

Heterogeneous results of the p16, p53 and ki67 in OT, XT/OT, CC/XT and XT/CC were observed. The three cell lines revealed EWS/FLI1 rearrangements. p16 gene was deleted only in one case. The deletion was detected by FISH and confirmed by PCR assays. A p53 alteration was found in the second case with monosomy and subsequently polysomic status of chromosome 17 during the evolution of CC. The PCR study revealed p53 mutation. The third case showed hypermethylation in the promoter of p16. The growth of the tumour in nude mice was more accelerated when the inoculation was performed from the CC/XT, increasing progressively over the passages. The third case did not reveal tumour growth in nude mice after the re-inoculation of CC/XT.

Conclusion

The study of several cores from original tumours and successive tumour passages in TMAs facilitated the analysis of the genetic alteration and protein expression in Ewing's tumours.
Literature
1.
go back to reference Aguilar-Mahecha A, Hassan S, Ferrario C, Basik M: Microarrays as validation strategies in clinical samples: tissue and protein microarrays. Omics. 2006, 10: 311-326. 10.1089/omi.2006.10.311.CrossRefPubMed Aguilar-Mahecha A, Hassan S, Ferrario C, Basik M: Microarrays as validation strategies in clinical samples: tissue and protein microarrays. Omics. 2006, 10: 311-326. 10.1089/omi.2006.10.311.CrossRefPubMed
2.
go back to reference Brown LA, Huntsman D: Fluorescent in situ hybridization on tissue microarrays: challenges and solutions. J Mol Histol. 2007, 38: 151-157. 10.1007/s10735-006-9069-y.CrossRefPubMed Brown LA, Huntsman D: Fluorescent in situ hybridization on tissue microarrays: challenges and solutions. J Mol Histol. 2007, 38: 151-157. 10.1007/s10735-006-9069-y.CrossRefPubMed
3.
go back to reference Kramer MW, Merseburger AS, Hennenlotter J, Kuczyk M: Tissue microarrays in clinical urology – Technical considerations. Scand J Urol Nephrol. 2007, 1-7. Kramer MW, Merseburger AS, Hennenlotter J, Kuczyk M: Tissue microarrays in clinical urology – Technical considerations. Scand J Urol Nephrol. 2007, 1-7.
4.
go back to reference Merseburger AS, Kuczyk MA, Serth J, Bokemeyer C, Young DY, Sun L: Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues. Oncol Rep. 2003, 10: 223-228.PubMed Merseburger AS, Kuczyk MA, Serth J, Bokemeyer C, Young DY, Sun L: Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues. Oncol Rep. 2003, 10: 223-228.PubMed
5.
go back to reference Tubbs RR, Pettay J, Barry TS, Swain E, Loftus M, Cook JR: The specificity of interphase FISH translocation probes in formalin fixed paraffin embedded tissue sections is readily assessed using automated staining and scoring of tissue microarrays constructed from murine xenografts. J Mol Histol. 2007, 38: 159-165. 10.1007/s10735-006-9066-1.CrossRefPubMed Tubbs RR, Pettay J, Barry TS, Swain E, Loftus M, Cook JR: The specificity of interphase FISH translocation probes in formalin fixed paraffin embedded tissue sections is readily assessed using automated staining and scoring of tissue microarrays constructed from murine xenografts. J Mol Histol. 2007, 38: 159-165. 10.1007/s10735-006-9066-1.CrossRefPubMed
6.
go back to reference Bridge RS, Rajaram V, Dehner LP, Pfeifer JD, Perry A: Molecular diagnosis of Ewing sarcoma/primitive neuroectodermal tumor in routinely processed tissue: a comparison of two FISH strategies and RT-PCR in malignant round cell tumors. Mod Pathol. 2006, 19: 1-8. 10.1038/modpathol.3800486.CrossRefPubMed Bridge RS, Rajaram V, Dehner LP, Pfeifer JD, Perry A: Molecular diagnosis of Ewing sarcoma/primitive neuroectodermal tumor in routinely processed tissue: a comparison of two FISH strategies and RT-PCR in malignant round cell tumors. Mod Pathol. 2006, 19: 1-8. 10.1038/modpathol.3800486.CrossRefPubMed
7.
go back to reference Folpe AL, Hill CE, Parham DM, O'Shea PA, Weiss SW: Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor. Am J Surg Pathol. 2000, 24: 1657-1662. 10.1097/00000478-200012000-00010.CrossRefPubMed Folpe AL, Hill CE, Parham DM, O'Shea PA, Weiss SW: Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor. Am J Surg Pathol. 2000, 24: 1657-1662. 10.1097/00000478-200012000-00010.CrossRefPubMed
8.
go back to reference Lipinski M, Braham K, Philip I, Wiels J, Philip T, Dellagi K: Phenotypic characterization of Ewing sarcoma cell lines with monoclonal antibodies. J Cell Biochem. 1986, 31: 289-296. 10.1002/jcb.240310406.CrossRefPubMed Lipinski M, Braham K, Philip I, Wiels J, Philip T, Dellagi K: Phenotypic characterization of Ewing sarcoma cell lines with monoclonal antibodies. J Cell Biochem. 1986, 31: 289-296. 10.1002/jcb.240310406.CrossRefPubMed
9.
go back to reference Llombart-Bosch A, Navarro S: Immunohistochemical detection of EWS and FLI-1 proteinss in Ewing sarcoma and primitive neuroectodermal tumors: comparative analysis with CD99 (MIC-2) expression. Appl Immunohistochem Mol Morphol. 2001, 9: 255-260. 10.1097/00022744-200109000-00010.PubMed Llombart-Bosch A, Navarro S: Immunohistochemical detection of EWS and FLI-1 proteinss in Ewing sarcoma and primitive neuroectodermal tumors: comparative analysis with CD99 (MIC-2) expression. Appl Immunohistochem Mol Morphol. 2001, 9: 255-260. 10.1097/00022744-200109000-00010.PubMed
10.
go back to reference Lopez-Guerrero JA, Pellin A, Noguera R, Carda C, Llombart-Bosch A: Molecular analysis of the 9p21 locus and p53 genes in Ewing family tumors. Lab Invest. 2001, 81: 803-814.CrossRefPubMed Lopez-Guerrero JA, Pellin A, Noguera R, Carda C, Llombart-Bosch A: Molecular analysis of the 9p21 locus and p53 genes in Ewing family tumors. Lab Invest. 2001, 81: 803-814.CrossRefPubMed
11.
go back to reference Coleman N, Roberts I: Re: Characterization of the A673 cell line (Ewing tumor) by molecular cytogenetic techniques. Cancer Genet Cytogenet. 2004, 148: 86-10.1016/S0165-4608(03)00209-7.CrossRefPubMed Coleman N, Roberts I: Re: Characterization of the A673 cell line (Ewing tumor) by molecular cytogenetic techniques. Cancer Genet Cytogenet. 2004, 148: 86-10.1016/S0165-4608(03)00209-7.CrossRefPubMed
12.
go back to reference Martinez-Ramirez A, Rodriguez-Perales S, Melendez B, Martinez-Delgado B, Urioste M, Cigudosa JC, Benitez J: Characterization of the A673 cell line (Ewing tumor) by molecular cytogenetic techniques. Cancer Genet Cytogenet. 2003, 141: 138-142. 10.1016/S0165-4608(02)00670-2.CrossRefPubMed Martinez-Ramirez A, Rodriguez-Perales S, Melendez B, Martinez-Delgado B, Urioste M, Cigudosa JC, Benitez J: Characterization of the A673 cell line (Ewing tumor) by molecular cytogenetic techniques. Cancer Genet Cytogenet. 2003, 141: 138-142. 10.1016/S0165-4608(02)00670-2.CrossRefPubMed
13.
go back to reference Subramaniam MM, Navarro S, Pellin A, Lopez-Guerrero JA, Carda C, Heredia Alvaro JA: Tissue microarray profiling of primary and xenotransplanted synovial sarcomas demonstrates the immunophenotypic similarities existing between SYT-SSX fusion gene confirmed, biphasic, and monophasic fibrous variants. Virchows Arch. 2006, 449: 435-447. 10.1007/s00428-006-0271-9.CrossRefPubMed Subramaniam MM, Navarro S, Pellin A, Lopez-Guerrero JA, Carda C, Heredia Alvaro JA: Tissue microarray profiling of primary and xenotransplanted synovial sarcomas demonstrates the immunophenotypic similarities existing between SYT-SSX fusion gene confirmed, biphasic, and monophasic fibrous variants. Virchows Arch. 2006, 449: 435-447. 10.1007/s00428-006-0271-9.CrossRefPubMed
14.
go back to reference Subramaniam MM, Noguera R, Piqueras M, Navarro S, Carda C, Pellin A: Evaluation of genetic stability of the SYT gene rearrangement by break-apart FISH in primary and xenotransplanted synovial sarcomas. Cancer Genet Cytogenet. 2007, 172: 23-28. 10.1016/j.cancergencyto.2006.07.008.CrossRefPubMed Subramaniam MM, Noguera R, Piqueras M, Navarro S, Carda C, Pellin A: Evaluation of genetic stability of the SYT gene rearrangement by break-apart FISH in primary and xenotransplanted synovial sarcomas. Cancer Genet Cytogenet. 2007, 172: 23-28. 10.1016/j.cancergencyto.2006.07.008.CrossRefPubMed
15.
go back to reference Hassan S, Ferrario C, Mamo A, Basik M: Tissue microarrays: emerging standard for biomarker validation. Curr Opin Biotechnol. 2007 Hassan S, Ferrario C, Mamo A, Basik M: Tissue microarrays: emerging standard for biomarker validation. Curr Opin Biotechnol. 2007
16.
go back to reference Milne AN, Sitarz R, Carvalho R, Polak MM, Ligtenberg M, Pauwels P: Molecular analysis of primary gastric cancer, corresponding xenografts, and 2 novel gastric carcinoma cell lines reveals novel alterations in gastric carcinogenesis. Hum Pathol. 2007, 38: 903-913. 10.1016/j.humpath.2006.12.010.CrossRefPubMed Milne AN, Sitarz R, Carvalho R, Polak MM, Ligtenberg M, Pauwels P: Molecular analysis of primary gastric cancer, corresponding xenografts, and 2 novel gastric carcinoma cell lines reveals novel alterations in gastric carcinogenesis. Hum Pathol. 2007, 38: 903-913. 10.1016/j.humpath.2006.12.010.CrossRefPubMed
17.
go back to reference Damron TA, Ward WG, Stewart A: Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base Report. Clin Orthop Relat Res. 2007, 459: 40-47. 10.1097/BLO.0b013e318059b8c9.CrossRefPubMed Damron TA, Ward WG, Stewart A: Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base Report. Clin Orthop Relat Res. 2007, 459: 40-47. 10.1097/BLO.0b013e318059b8c9.CrossRefPubMed
18.
go back to reference Szuhai K, Ijszenga M, Tanke HJ, Rosenberg C, Hogendoorn PC: Molecular cytogenetic characterization of four previously established and two newly established Ewing sarcoma cell lines. Cancer Genet Cytogenet. 2006, 166: 173-179. 10.1016/j.cancergencyto.2005.11.006.CrossRefPubMed Szuhai K, Ijszenga M, Tanke HJ, Rosenberg C, Hogendoorn PC: Molecular cytogenetic characterization of four previously established and two newly established Ewing sarcoma cell lines. Cancer Genet Cytogenet. 2006, 166: 173-179. 10.1016/j.cancergencyto.2005.11.006.CrossRefPubMed
19.
go back to reference Szuhai K, M IJ, Tanke HJ, Taminiau AH, de Schepper A, van Duinen SG: Detection and molecular cytogenetic characterization of a novel ring chromosome in a histological variant of Ewing sarcoma. Cancer Genet Cytogenet. 2007, 172: 12-22. 10.1016/j.cancergencyto.2006.07.007.CrossRefPubMed Szuhai K, M IJ, Tanke HJ, Taminiau AH, de Schepper A, van Duinen SG: Detection and molecular cytogenetic characterization of a novel ring chromosome in a histological variant of Ewing sarcoma. Cancer Genet Cytogenet. 2007, 172: 12-22. 10.1016/j.cancergencyto.2006.07.007.CrossRefPubMed
20.
go back to reference Dauphinot L, De Oliveira C, Melot T, Sevenet N, Thomas V, Weissman BE, Delattre O: Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression. Oncogene. 2001, 20: 3258-3265. 10.1038/sj.onc.1204437.CrossRefPubMed Dauphinot L, De Oliveira C, Melot T, Sevenet N, Thomas V, Weissman BE, Delattre O: Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression. Oncogene. 2001, 20: 3258-3265. 10.1038/sj.onc.1204437.CrossRefPubMed
21.
go back to reference Hamelin R, Flejou JF, Muzeau F, Potet F, Laurent-Puig P, Fekete F, Thomas G: TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus. Gastroenterology. 1994, 107: 1012-1018.CrossRefPubMed Hamelin R, Flejou JF, Muzeau F, Potet F, Laurent-Puig P, Fekete F, Thomas G: TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus. Gastroenterology. 1994, 107: 1012-1018.CrossRefPubMed
22.
go back to reference Hamelin R, Zucman J, Melot T, Delattre O, Thomas G: p53 mutations in human tumors with chimeric EWS/FLI-1 genes. Int J Cancer. 1994, 57: 336-340. 10.1002/ijc.2910570308.CrossRefPubMed Hamelin R, Zucman J, Melot T, Delattre O, Thomas G: p53 mutations in human tumors with chimeric EWS/FLI-1 genes. Int J Cancer. 1994, 57: 336-340. 10.1002/ijc.2910570308.CrossRefPubMed
23.
go back to reference Huang HY, Illei PB, Zhao Z, Mazumdar M, Huvos AG, Healey JH: Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse. J Clin Oncol. 2005, 23: 548-558. 10.1200/JCO.2005.02.081.CrossRefPubMed Huang HY, Illei PB, Zhao Z, Mazumdar M, Huvos AG, Healey JH: Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse. J Clin Oncol. 2005, 23: 548-558. 10.1200/JCO.2005.02.081.CrossRefPubMed
24.
go back to reference Kovar H, Auinger A, Jug G, Aryee D, Zoubek A, Salzer-Kuntschik M, Gadner H: Narrow spectrum of infrequent p53 mutations and absence of MDM2 amplification in Ewing tumours. Oncogene. 1993, 8: 2683-2690.PubMed Kovar H, Auinger A, Jug G, Aryee D, Zoubek A, Salzer-Kuntschik M, Gadner H: Narrow spectrum of infrequent p53 mutations and absence of MDM2 amplification in Ewing tumours. Oncogene. 1993, 8: 2683-2690.PubMed
25.
go back to reference Kovar H, Jug G, Aryee DN, Zoubek A, Ambros P, Gruber B: Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors. Oncogene. 1997, 15: 2225-2232. 10.1038/sj.onc.1201397.CrossRefPubMed Kovar H, Jug G, Aryee DN, Zoubek A, Ambros P, Gruber B: Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors. Oncogene. 1997, 15: 2225-2232. 10.1038/sj.onc.1201397.CrossRefPubMed
26.
go back to reference Kovar H, Pospisilova S, Jug G, Printz D, Gadner H: Response of Ewing tumor cells to forced and activated p53 expression. Oncogene. 2003, 22: 3193-3204. 10.1038/sj.onc.1206391.CrossRefPubMed Kovar H, Pospisilova S, Jug G, Printz D, Gadner H: Response of Ewing tumor cells to forced and activated p53 expression. Oncogene. 2003, 22: 3193-3204. 10.1038/sj.onc.1206391.CrossRefPubMed
Metadata
Title
Tissue microarrays: applications in study of p16 and p53 alterations in Ewing's cell lines
Authors
Rosa Noguera
Isidro Machado
Marta Piqueras
Jose Antonio Lopez-Guerrero
Samuel Navarro
Empar Mayordomo
Antonio Pellin
Antonio Llombart-Bosch
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue Special Issue 1/2008
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/1746-1596-3-S1-S27

Other articles of this Special Issue 1/2008

Diagnostic Pathology 1/2008 Go to the issue